Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZC and Enhanced Nutrition in Dialysis Patients
NCT04997161Phase 4Terminated
- Sponsor
- AstraZeneca
- Start
- Aug 2021
- Primary completion
- Nov 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of sodium zirconium cyclosilicate in Hyperkalemia, sponsored by AstraZeneca. Started Aug 2021; status: terminated.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
Hyperkalemia
Beyond the preview
Go deeper on NCT04997161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997161.